Type 1 Diabetes

Latest News

Telemedicine Care May Improve Management of Patients With Type 1 Diabetes

By

Amit Akirov, MD

Researchers explored the effects of a telemedicine visit on care in patients with T1D.

Increased Risk for Psychiatric Disorders in Adolescents, Emerging Adults With Diabetes

By

Amit Akirov, MD

Adolescence and emerging adulthood represent a complicated stage for patients with T1D. Access to mental health services during this transition is critical.

Severe Hypoglycemia Linked to Worse Cognition in Older Patients With T1D

Both recent severe hypoglycemia (SH) and lifetime SH are associated with worse cognition among older adults with type 1 diabetes.

Study Explores Factors Affecting Glycemic Control in T1D

Patients with type 1 diabetes with optimal and suboptimal glycemic control differ with respect to clinical and health care utilization factors.

Intermittently Scanned CGM May Reduce Hypoglycemia in T1D

Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.

FDA Approves Mealtime Insulin Option for Pediatric Patients With Diabetes

By

Diana Ernst, RPh

The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.

High Lipoprotein(a) Is a Risk Factor for CVD in Type 1 Diabetes

For patients with type 1 diabetes, lipoprotein(a) [Lp(a)] is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease.

Suicide and Type 1 Diabetes: Importance of Risk Assessment in Young Patients

By

Amit Akirov, MD

Assessment of suicide risk as part of routine pediatric type 1 diabetes care is feasible and necessary.

ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications

By

Rachael Beairsto

The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.

Preterm Birth May Increase Risk for Type 1 and Type 2 Diabetes

By

Amit Akirov, MD

The risk for type 1 and type 2 diabetes from childhood into adulthood is increased in preterm-born individuals.

Type 1 Diabetes May Increase Progression of Coronary Artery Calcium During Menopause

For women going through menopause, type 1 diabetes is associated with higher coronary artery calcium volume and accelerated progression of CAC over time.

Insulin Glargine 300 U/mL Approved for Pediatric Patients With Diabetes

By

Brian Park, PharmD

The FDA has expanded the indication for Toujeo (insulin glargine; Sanofi) 300 Units/mL to include treatment of pediatric patients aged ≥6 years with diabetes mellitus.

Examining Changes in BMI From Childhood to Puberty in Type 1 Diabetes

By

Amit Akirov, MD

The high prevalence of overweight and obesity in youth with T1D was consistent across a multinational cohort and persistent over time.

Alarm Settings of CGM Systems Affect Glucose Control in T1D

Adjusting glucose thresholds for hypoglycemia and hyperglycemia alarms in continuous glucose monitoring can help achieve better glucose control in patients with type 1 diabetes.

Medicaid Expansion Has a Positive Impact on Diabetes Management

By

Amit Akirov, MD

Medicaid expansion under the Affordable Care Act was found to improve self-reported diabetes management and self-reported health outcomes in patients with type 1 or type 2 diabetes.

Topical Wound Oxygen Therapy Improves Healing of Diabetic Foot Ulcers

By

Amit Akirov, MD

Combination of cyclical pressure Topical Wound Oxygen (TWO2) therapy with optimal standard of care improves healing and can reduce recurrence of diabetic foot ulcer.

Closed-Loop System Better Controls Blood Glucose Than Sensor-Augmented Insulin Pump

By

Amit Akirov, MD

A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.

Fast-Acting Insulin Approved for Use in Insulin Infusion Pumps

By

Brian Park, PharmD

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.

Glycemic Control Worse Than Previously Thought in Adults With T1D

For adults with type 1 diabetes, glycemic control may be worse than previously thought, and rates of all complications increase with increasing hemoglobin A1c.

Plasma Copeptin Level Linked to Lower-Extremity Amputations in Diabetes

By

Hannah Dellabella

Researchers assessed whether plasma copeptin, a surrogate marker of vasopressin, is associated with lower-extremity amputation in diabetes.